Company Number: 12838736

Analysis Date: 2025-07-29 13:53 UTC

1. Market Position
   CheamSiam Ltd operates within the "Other human health activities" sector, likely catering to niche or specialized health services. As a relatively young private limited company incorporated in 2020, it is positioned as a small player with limited scale but focused operations. The company’s financials suggest a modest asset base with limited turnover, implying a localized or specialized market presence rather than broad national or international reach.

2. Strategic Assets

• Tangible Fixed Assets: With net tangible fixed assets of approximately £41k, the company holds physical resources likely central to service delivery, providing operational stability.
• Equity Growth: Shareholders' funds increased from £3.8k in 2023 to £9k in 2024, indicating improving financial health and possibly profitability or capital injections.
• Low Employee Base: Employing an average of 2 people suggests a lean organizational structure, which can translate to low overheads and flexibility.
• Strong Cash Position Relative to Size: Although cash has decreased from £20.6k in 2023 to £7.4k in 2024, maintaining liquidity supports operational continuity.

3. Growth Opportunities

• Service Expansion: Given the health sector classification, CheamSiam could explore expanding specialized services or diversifying into complementary health activities to increase revenue streams.
• Asset Utilization: Optimization of tangible fixed assets (e.g., equipment and premises) could enhance service capacity or efficiency.
• Leveraging Operational Agility: The small scale allows the company to rapidly adapt to market demand and implement innovative health solutions or niche offerings that larger competitors may overlook.
• Market Penetration: Targeted marketing and partnerships within the local or regional health ecosystem could improve client base and revenue.

4. Strategic Risks

• High Long-Term Liabilities: Creditors falling due after one year amount to £36.9k, a significant figure relative to net assets (£9k), potentially constraining financial flexibility and increasing debt servicing risks.
• Declining Liquidity: Cash reserves have significantly reduced year-over-year, which may affect the ability to sustain operations or invest in growth without external financing.
• Limited Scale and Market Reach: With a very small team and limited turnover, the company may face challenges competing against larger firms with more resources or broader offerings.
• Dependency on Single Director: The company’s governance appears concentrated with one director, which could pose risks related to leadership continuity and decision-making bandwidth.
• Small Company Filing Exemptions: While beneficial for compliance efficiency, limited public disclosure restricts external stakeholder visibility, potentially affecting trust and partnership opportunities.